Maryam Ali

Maryam Ali is an experienced Assay Development Scientist at invoX Pharma since November 2022, specializing in bioanalytical and biomarker support for multi-specific therapeutic antibodies throughout pre-candidate selection and early clinical trials. Expertise includes the development and validation of immunoassays as well as in-vitro assay development to elucidate therapeutic antibody mechanisms of action. Previous roles include Scientist at Osler Diagnostics, focusing on high sensitivity immunoassay development for point of care IVD, and Senior Laboratory Analyst at Eurofins Bioanalytical Services, where assay development and validation were conducted in GLP/GCP compliant environments. Educational background includes a Master's degree in Biomedical Science with a focus on Immunology and Biochemistry from the University of Westminster and a Bachelor's degree in Biomedical Sciences from De Montfort University.